GLOBAL MEDICAL POLYETHERETHERKETONE MARKET

INTRODUCTION

 Medical Due to its outstanding qualities, polyetheretherketone (PEEK), a high-performance thermoplastic polymer, is increasingly being used in a variety of medical applications.

The polyaryletherketone (PAEK) family includes PEEK, which is renowned for its radiolucency, mechanical toughness, and chemical resistance.

It is a valuable material for implants and medical devices because of these qualities.

PEEK is biocompatible, which means that when it comes into contact with live tissues, it has no negative effects or harmful responses.

This quality qualifies it for use in implants and other medical equipment that comes into contact with people's bodies.

It is radiolucent, therefore it doesn't appreciably interfere with X-rays or other imaging processes.

For medical implants and equipment used in diagnostic procedures, this quality is essential.

Similar to bone, PEEK has exceptional mechanical strength and stiffness.

Because it can sustain the strains and pressures that the human body experiences, it is appropriate for load-bearing applications.

PEEK has a high level of chemical resistance, including to body fluids, acids, and bases.

In challenging settings, this resistance guarantees the durability and integrity of medical devices made of PEEK.

Although PEEK has several benefits, it is crucial to remember that any medical application must carefully take into account the unique material qualities, design, and regulatory requirements in order to assure safety and effectiveness.

Before being permitted for use in clinical settings, medical devices and implants constructed of PEEK often go through a thorough testing and regulatory review process.

PEEK's natural appearance and biocompatibility make it a popular material for dental crowns, bridges, and dentures.

GLOBAL MEDICAL POLYETHERETHERKETONE MARKET SIZE AND FORECAST

The Global medical polyetheretherketone market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.

NEW PRODUCT LAUNCH

For the medical technology sector, Evonik has created a novel osteoconductive polyether ether ketone (PEEK) that enhances the fusing between the bone and the implant.

The specialized chemicals firm is introducing a new product line of implant materials of the next generation that are PEEK-based under the name VESTAKEEP Fusion in conjunction with the release of the new biomaterial.

Biphasic calcium phosphate, a unique functional additive, was used to create the new PEEK material's osteoconductive properties, which promote faster bone cell adhesion to implants.

This has a positive impact on the process of fusion, or osteointegration, at the implant-to-bone interface.

In turn, this will hasten bone fusion and recovery.

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many medical polyetheretherketone are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global medical polyetheretherketone and key vendor selection criteria
3. Where is the medical polyetheretherketone manufactured? What is the average margin per unit?
4. Market share of Global medical polyetheretherketone market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global medical polyetheretherketone in-house
6. key predictions for next 5 years in Global medical polyetheretherketone market
7. Average B-2-B medical polyetheretherketone market price in all segments
8. Latest trends in medical polyetheretherketone market, by every market segment
9. The market size (both volume and value) of the medical polyetheretherketone market in 2023-2030 and every year in between?
10. Production breakup of medical polyetheretherketone market, by suppliers and their OEM relationship